Commercialized a highly effective skin cancer scanning device

Used for over 12 years and supported by more than 15 published clinical studies

Sponsored
Message: Re: Updates on past news releases

Thank you very much for your reply, much appreciated.

 

I did not have an expectation that you would respond to each item because as you stated the time involved would have been extensive to say the least. I put the list merely to provide backup to my statement regarding 1 hit wonders. As an investor we would be concerned that no follow up was by default not good news or results. 

I have been invested in MDX since 2016 and still hold out hope that your product can be a game changer for dermatology not just teledermatology. 

Here's to a bright future for MDX and its long term investors.

Share
New Message
Please login to post a reply